SHG:603127 - Joinn Laboratories (China) Co Ltd

Joinn Laboratories(China)Co
Sector: Health Care, Industry: Life Sciences Tools & Services

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized Adjust Display Metrics

Show %	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	Graph
Insider Holdings (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	59.17% -9.1%	54.42% -8.0%	48.41% -11.0%
Net Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	36.76% 25.5%	47.37% 28.9%	16.71% -64.7%
Gross Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	48.73% -5.2%	47.9% -1.7%	42.62% -11.0%
Operating Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	29.8% 6.2%	31.62% 6.1%	26.66% -15.7%
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.52B 41.0%	2.27B 49.5%	2.38B 4.8%
Total Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	8.54B 292.9%	10.36B 21.4%	10.03B -3.3%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.39B 46.4%	2.17B 56.1%	1.75B -19.7%
Total Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	7.14B 483.7%	8.18B 14.7%	8.28B 1.2%
Operating CashFlow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	685.66M 60.1%	971.07M 41.6%	622.88M -35.9%
Beginning Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	305.04M 72.4%	4.15B 1260.6%	2.9B -30.1%
End Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	4.15B 1260.6%	2.9B -30.1%	2.85B -1.6%
Free Cash Flow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	448.41M 60.5%	696.23M 55.3%	430.15M -38.2%
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	556.42M 77.4%	1.07B 92.9%	391.55M -63.5%
Diluted Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.764 51.3%	1.43 87.1%	0.53 -62.9%
Return On Equity (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	13.34% -56.1%	14.02% 5.1%	4.82% -65.6%
Return On Assets (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	10.41% -39.3%	11.37% 9.2%	3.89% -65.7%